Kinnate Biopharma Inc. ( KNTE) - Stock Earnings
Stock symbol KNTE is outdated, potentially delisted? Maybe it is available on other exchange?
KNTE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -31.2 million USD | — USD |
| 2023Q2 | -31.9 million USD | — USD |
| 2023Q3 | -30.7 million USD | — USD |
KNTE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -89.4 million USD | 0 USD |
| 2022 | -114.0 million USD | 0 USD |
| 2023 | -127.2 million USD | — USD |
KNTE
Price: $2.65
52 week price:
Earnings Per Share: -2.78 USD
P/E Ratio: -0.84
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 55200
Market Capitalization: 125.0 million